|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | St. Jude Medical, Inc. (STJ), a manufacturer of cardiovascular medical devices. |
|---|---|
| Transferring Party | Advanced Neuromodulation Systems, Inc. (ANSI), a manufacturer of implantable neuromodulation devices for disorders of the central nervous system. |
| Sector | Medical Devices |
| Date | November 29, 2005 |
| Analysis Provides St. Jude with a complementary technology platform in a rapidly-growing and under penetrated market gaining an immediate footprint, a broad portfolio and strengthening its international presence. The technology crossover will benefit both neuromodulation and cardiac rhythm management. Deal value: $1.3 billion. Medtronic leads the sector, with ANSI in second and Cyberonics in third. STJ sought to buy Cyberonics for $525 million in 2004. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |